Transcenta

Transcenta: A Global Biotherapeutics Company

Transcenta is a global biotherapeutics company that specializes in the discovery, research and development, and manufacturing of antibody-based biotherapeutics. The company has a strong focus on innovation and collaboration to bring new treatments to patients around the world.

With a team of experienced scientists, Transcenta is committed to advancing the field of biotherapeutics through cutting-edge research and development. The company's state-of-the-art facilities are equipped with the latest technology for drug discovery, process development, and manufacturing.

Transcenta's mission is to improve patient outcomes by developing innovative therapies for diseases with unmet medical needs. The company's pipeline includes several promising candidates for cancer, autoimmune disorders, infectious diseases, and other conditions.

Discovery

At Transcenta, the discovery process begins with identifying potential targets for therapeutic intervention. This involves extensive research into disease mechanisms and pathways to identify proteins or other molecules that could be targeted by antibodies.

Once potential targets have been identified, Transcenta uses its proprietary platform technologies to generate high-quality antibodies against these targets. These technologies include phage display libraries, hybridoma technology, transgenic animal platforms (such as mice or rabbits), as well as humanization techniques.

The goal of this stage is to identify lead candidates that show high specificity and affinity towards their target molecules while minimizing off-target effects. These lead candidates are then further optimized through engineering techniques such as affinity maturation or Fc optimization.

Research & Development

After lead candidates have been identified through the discovery process at Transcenta labs in China or US-based R&D center in Princeton NJ., they undergo rigorous preclinical testing before entering clinical trials. This includes safety studies in animals as well as pharmacokinetic (PK) studies to determine how drugs are absorbed into the body over time.

Once preclinical testing has been completed successfully at our GMP facility located in Suzhou China , clinical trials can begin. Clinical trials involve testing drugs on human subjects under carefully controlled conditions according to regulatory guidelines set forth by agencies such as FDA or EMA .

Manufacturing

Transcenta has state-of-the-art facilities located across China including Suzhou , Hangzhou , Beijing which allows us full control over our supply chain from start-to-finish . Our manufacturing capabilities include cell line development , upstream processing (fermentation), downstream processing (purification), formulation & fill/finish operations .

Our facilities are designed according cGMP standards ensuring quality control throughout all stages of production . We also employ strict environmental controls within our cleanrooms where products are manufactured under sterile conditions .

Conclusion

In conclusion , Transcenta is a global leader in antibody-based biotherapeutics discovery & development . With its strong focus on innovation & collaboration along with state-of-the-art facilities across China including Suzhou,Hangzhou&Beijing it offers full integration from early-stage drug discovery all way up until commercialization . Its commitment towards improving patient outcomes makes it an ideal partner for pharmaceutical companies looking develop novel therapies against various diseases including cancer autoimmune disorders infectious diseases etc..